Ovarian Cancer: Methods and Protocols

Portada
John M. S. Bartlett
Springer Science & Business Media, 2 feb 2008 - 817 páginas
If there is one aspect of current cancer research that represents a major ch- lenge in both novice and experienced researchers, it is the rapid advance in our understanding of the disease. Researchers can be required to switch from analysis of gene expression to kinetics of protein activation, from genetic studies to the analysis of protein funtion. Cancers are highly complex disease systems and researchers aiming to understand the functioning of cancer systems require access to a wide range of laboratory techiques from a broad range of research disciplines. Increasingly, however, published methods are incomplete or refer back to a series of previous publications each containing only a small part of the complete pro- col. The aim of Ovarian Cancer: Methods and Protocols is to provide for ovarian cancer researchers in the first instance, a laboratory handbook that will facilitate research into cancer systems by providing a series of expert protocols, with proven efficacy, across a broad range of technical expertise. Thus, there are sections on tumor genetics and cellular signal transduction, as well as sections on apoptosis and RNA analysis. The value of Ovarian Cancer: Methods and Protocols to the ovarian cancer researcher will, I trust, be considerably enhanced by (1) the provision of a series of overviews relating to the biology, diagnosis, and treatment of this important neoplasm, and (2) the provision of a series of technical overviews introducing each part that provides an expert review of the applications and pitfalls of the various techniques included.
 

Páginas seleccionadas

Índice

INTRODUCTION TO OVARIAN CANCER
3
Alterations in Oncogenes Tumor Suppressor Genes
37
Alistair R W Williams
49
Tumor Markers in Screeening for Ovarian Cancer
61
Primary Surgical Management of Ovarian Cancer
75
Hamilton and Steven W Johnson
89
An Overview
109
a Prognostic Factor in Patients with Epithelial Ovarian Cancer
121
for Mismatch Repair Proteins
383
Karl Dobianer Michael Medl and Jürgen Spona
389
A Technical Overview
399
Anders Gobl and Rudi Henriksen 46 mRNA Detection by In Situ RTPCR
411
Assay Analysis of mRNA for TGFβ
431
RTPCR Quantitation of HSP60 mRNA Expression
439
The Effects of Butyrate and the Role of cmyc in N 1 Ovarian
449
Sellar Genevieve J Rabiasz Barbara Smith
459

Technical Review
145
Establishment of Ovarian Cancer Cell Lines
155
Culture and Characterization of Human Ovarian Surface Epithelium
169
Contents
171
Spinner
175
p53 Transfectants in Ovarian Cancer
187
Cell Lines as Xenografts
199
CYTOGENETICS
207
Interphase Cytogenetics in Frozen Ovarian Tumor Tissue
215
Susann Neubauer and Thomas Liehr 25 Rapid Identification of Chromosomes Using Primed
223
Gene Amplification of cermB2 Detected by FISH
237
Chromosome Microdissection for Detection of Subchromosomal
247
Quantitation of FISH Signals in Archival Tumors
253
Comparative Genomic Hybridization for the Analysis of Unbalanced
261
A Technical Overview
273
Extraction of DNA from Microdissected Archival Tissues
291
RFLP Molecular Analysis of the UrokinaseType Plasminogen
299
PCR Microsatellite Analysis of LOH in Ovarian Tumors
307
of Loss of Heterozygosity
315
in Ovarian Tumors
323
p53 Deletion and Insertion Mutations
329
Transfer of Human Chromosome 3 to an Ovarian Carcinoma
337
Doubleand CompetitiveDifferential
347
One Dimensional Genome ScanningDetection of Genomic
357
Mapping of Tumor Suppressor Genes in Ovarian Cancer
365
Detection of the Replication Error Phenotype in Ovarian
375
PROTEIN EXPRESSION
471
Measurement of IGF1 Receptor Content in Tissues
485
nm23 Protein Expression by Western Blotting in Patients with Epithelial
499
Simultaneous Flow Cytometric Detection of
515
Quantitative Immunohistochemistry of Estrogen and Progesterone
535
Quantitative Analysis of Cell Surface
545
Immunoprecipitation to Determine JAK Kinase Activation in Response
567
Direct Kinase Assay Screening for Inhibitors of MAP Kinase
583
Induction of cfos Gene Expression by UrokinaseType
597
to Lysophospholipids
611
A Novel and Simple Method to Assay the Activity of Individual
633
A Technical Overview
651
Measurement of Apoptotic Cells by Flow Cytometry Tunnel Assay
665
Use of Diphenylamine in the Detection of Apoptosis
679
Differential Expression of ApoptosisAssociated Genes
687
Detection of Telomerase Activity by PCRBased Assay
701
A Technical Overview
713
Developing AntiHER2neu SingleChain Fv Fragments
729
Direction of the Recognition Specificity of Cytotoxic T Cells Toward
749
Eradication of cerbB2 Positive Ovarian Cancer Cells Mediated
757
Spreading of Ovarian Cancer Cells
769
E1AMediated Gene Therapy
775
p53 Adenovirus as Gene Therapy for Ovarian Cancer
783
Bispecific Antibody MDX210 for Treatment of Advanced Ovarian
793
Index
807
Página de créditos

Otras ediciones - Ver todo

Términos y frases comunes

Información bibliográfica